MintNeuro

Executive Summary

MintNeuro is a UK-based semiconductor company founded in 2020, specializing in ultra-low-power integrated circuits (ICs) for neural implants. Its chips enable safer, smarter, and more scalable brain-computer interfaces (BCIs) and active implantable medical devices (AIMDs). As a technology partner to medical device companies and research institutions, MintNeuro addresses a critical hardware bottleneck in neurotechnology. The company operates at the pre-clinical stage, focusing on design and supply of purpose-built ICs that reduce power consumption and enhance safety for implantable devices. With the growing demand for advanced BCIs and neuroprosthetics, MintNeuro's foundational hardware positions it as a key enabler in the neural interface ecosystem. The company's UK base provides access to a strong biomedical research cluster and potential government support for neurotech innovation.

Upcoming Catalysts (preview)

• Q3 2026Completion of first prototype IC for neural recording and stimulation75% success
• Q4 2026Strategic partnership with a major medical device company for co-development60% success
• Q2 2027Series A funding round closure to scale production and expand team70% success